180 related articles for article (PubMed ID: 29903602)
1. Toxic epidermal necrolysis data from the CELESTE multinational registry. Part II: Specific systemic and local risk factors for the development of infectious complications.
Lipový B; Holoubek J; Hanslianová M; Cvanová M; Klein L; Grossová I; Zajíček R; Bukovčan P; Koller J; Baran M; Lengyel P; Eimer L; Jandová M; Košťál M; Brychta P;
Burns; 2018 Sep; 44(6):1561-1572. PubMed ID: 29903602
[TBL] [Abstract][Full Text] [Related]
2. Toxic epidermal necrolysis data from the CELESTE multinational registry. Part I: Epidemiology and general microbiological characteristics.
Lipový B; Holoubek J; Hanslianová M; Cvanová M; Klein L; Grossová I; Zajíček R; Bukovčan P; Koller J; Baran M; Lengyel P; Eimer L; Jandová M; Košťál M; Brychta P;
Burns; 2018 Sep; 44(6):1551-1560. PubMed ID: 29886114
[TBL] [Abstract][Full Text] [Related]
3. Retrospective study of 213 cases of Stevens-Johnson syndrome and toxic epidermal necrolysis from China.
Yang L; Shou YH; Li F; Zhu XH; Yang YS; Xu JH
Burns; 2020 Jun; 46(4):959-969. PubMed ID: 31898979
[TBL] [Abstract][Full Text] [Related]
4. Combination therapy of intravenous immunoglobulin and corticosteroid in the treatment of toxic epidermal necrolysis and Stevens-Johnson syndrome: a retrospective comparative study in China.
Yang Y; Xu J; Li F; Zhu X
Int J Dermatol; 2009 Oct; 48(10):1122-8. PubMed ID: 19775409
[TBL] [Abstract][Full Text] [Related]
5. Treatment of toxic epidermal necrolysis by a multidisciplinary team. A review of literature and treatment results.
Papp A; Sikora S; Evans M; Song D; Kirchhof M; Miliszewski M; Dutz J
Burns; 2018 Jun; 44(4):807-815. PubMed ID: 29627131
[TBL] [Abstract][Full Text] [Related]
6. Toxic epidermal necrolysis: performance of SCORTEN and the score-based comparison of the efficacy of corticosteroid therapy and intravenous immunoglobulin combined therapy in China.
Zhu QY; Ma L; Luo XQ; Huang HY
J Burn Care Res; 2012; 33(6):e295-308. PubMed ID: 22955159
[TBL] [Abstract][Full Text] [Related]
7. High-dose intravenous immunoglobulins in the treatment of Stevens-Johnson syndrome and toxic epidermal necrolysis in Chinese patients: a retrospective study of 82 cases.
Chen J; Wang B; Zeng Y; Xu H
Eur J Dermatol; 2010; 20(6):743-7. PubMed ID: 20952352
[TBL] [Abstract][Full Text] [Related]
8. Toxic epidermal necrolysis (TEN): the Chelsea and Westminster Hospital wound management algorithm.
Abela C; Hartmann CE; De Leo A; de Sica Chapman A; Shah H; Jawad M; Bunker CB; Williams GJ; Leon-Villapalos J
J Plast Reconstr Aesthet Surg; 2014 Aug; 67(8):1026-32. PubMed ID: 24860933
[TBL] [Abstract][Full Text] [Related]
9. Assessment of Treatment Approaches and Outcomes in Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: Insights From a Pan-European Multicenter Study.
Kridin K; Brüggen MC; Chua SL; Bygum A; Walsh S; Nägeli MC; Kucinskiene V; French L; Tétart F; Didona B; Milpied B; Ranki A; Salavastru C; Brezinová E; Divani-Patel S; Lorentzen T; Nagel JL; Valiukeviciene S; Karpaviciute V; Tiplica GS; Oppel E; Oschmann A; de Prost N; Vorobyev A; Ingen-Housz-Oro S
JAMA Dermatol; 2021 Oct; 157(10):1182-1190. PubMed ID: 34431984
[TBL] [Abstract][Full Text] [Related]
10. Guidelines for the management of Stevens-Johnson syndrome/toxic epidermal necrolysis: An Indian perspective.
Gupta LK; Martin AM; Agarwal N; D'Souza P; Das S; Kumar R; Pande S; Das NK; Kumaresan M; Kumar P; Garg A; Singh S
Indian J Dermatol Venereol Leprol; 2016; 82(6):603-625. PubMed ID: 27716721
[TBL] [Abstract][Full Text] [Related]
11. Retrospective review of Stevens-Johnson syndrome/toxic epidermal necrolysis treatment comparing intravenous immunoglobulin with cyclosporine.
Kirchhof MG; Miliszewski MA; Sikora S; Papp A; Dutz JP
J Am Acad Dermatol; 2014 Nov; 71(5):941-7. PubMed ID: 25087214
[TBL] [Abstract][Full Text] [Related]
12. Cyclosporine in Stevens Johnson syndrome and toxic epidermal necrolysis and retrospective comparison with systemic corticosteroid.
Singh GK; Chatterjee M; Verma R
Indian J Dermatol Venereol Leprol; 2013; 79(5):686-92. PubMed ID: 23974585
[TBL] [Abstract][Full Text] [Related]
13. Nine years of a single referral center management of Stevens-Johnson syndrome and toxic epidermal necrolysis (Lyell's syndrome).
Monteiro D; Egipto P; Barbosa J; Horta R; Amarante J; Silva P; Silva A
Cutan Ocul Toxicol; 2017 Jun; 36(2):163-168. PubMed ID: 27487073
[TBL] [Abstract][Full Text] [Related]
14. Cyclosporine treatment for Stevens-Johnson syndrome/toxic epidermal necrolysis: Retrospective analysis of a cohort treated in a specialized referral center.
Lee HY; Fook-Chong S; Koh HY; Thirumoorthy T; Pang SM
J Am Acad Dermatol; 2017 Jan; 76(1):106-113. PubMed ID: 27717620
[TBL] [Abstract][Full Text] [Related]
15. Pediatric toxic epidermal necrolysis: using SCORTEN and predictive models to predict morbidity when a focus on mortality is not enough.
Beck A; Quirke KP; Gamelli RL; Mosier MJ
J Burn Care Res; 2015; 36(1):167-77. PubMed ID: 25559731
[TBL] [Abstract][Full Text] [Related]
16. Epidemiology and costs of patients with toxic epidermal necrolysis: a 27-year retrospective study.
Oen IM; van der Vlies CH; Roeleveld YW; Dokter J; Hop MJ; van Baar ME
J Eur Acad Dermatol Venereol; 2015 Dec; 29(12):2444-50. PubMed ID: 26416341
[TBL] [Abstract][Full Text] [Related]
17. Steven Johnson Syndrome and Toxic Epidermal Necrolysis in a burn unit: A 15-year experience.
McCullough M; Burg M; Lin E; Peng D; Garner W
Burns; 2017 Feb; 43(1):200-205. PubMed ID: 27554629
[TBL] [Abstract][Full Text] [Related]
18. The role of intravenous immunoglobulin in toxic epidermal necrolysis: a retrospective analysis of 64 patients managed in a specialized centre.
Lee HY; Lim YL; Thirumoorthy T; Pang SM
Br J Dermatol; 2013 Dec; 169(6):1304-9. PubMed ID: 24007192
[TBL] [Abstract][Full Text] [Related]
19. Pediatric toxic epidermal necrolysis: an institutional review of patients admitted to an intensive care unit.
Hamilton GM; Fish J
J Burn Care Res; 2013; 34(6):e351-8. PubMed ID: 23816996
[TBL] [Abstract][Full Text] [Related]
20. Stevens-Johnson syndrome and toxic epidermal necrolysis: a review of the literature.
Letko E; Papaliodis DN; Papaliodis GN; Daoud YJ; Ahmed AR; Foster CS
Ann Allergy Asthma Immunol; 2005 Apr; 94(4):419-36; quiz 436-8, 456. PubMed ID: 15875523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]